drugset / Trial / NCT02729376
Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Galeterone
NaSingle-groupOpen-labelBasic science
Summary
This is an open label, single dose, 1 period study of \[14C\] galeterone.
Timeline
- Start
- 2016-03
- Primary completion
- 2016-04
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | galeterone | Small molecule | 2600 mg | Oral |
Indications
No indication recorded.